In Vivo mouse imaging and spectroscopy in drug discovery

被引:88
作者
Beckmann, Nicolau
Kneuer, Rainer
Gremlich, Hans-Ulrich
Karmouty-Quintana, Harry
Ble, Francois-Xavier
Mueller, Matthias
机构
[1] Novartis Inst Biomed Res, Discovery Technol, CH-4002 Basel, Switzerland
[2] Novartis Inst Biomed Res, Models Dis Ctr, CH-4002 Basel, Switzerland
[3] Kings Coll London, Sackler Inst Pulm Pharmacol, London SE1 1UL, England
[4] Univ Strasbourg 1, Fac Pharm, F-67401 Illkirch Graffenstaden, France
关键词
bioluminescence; imaging; MRI; micro-PET; mouse; near-infrared fluorescence imaging; transgenic mice; ultrasound;
D O I
10.1002/nbm.1153
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Imaging modalities such as micro-computed tomography (micro-CT), micro-positron emission tomography (micro-PET), high-resolution MRI, optical imaging, and high-resolution ultrasound have become invaluable tools in preclinical pharmaceutical research. They can be used to non-invasively investigate, in vivo, rodent biology and metabolism, disease models, and pharmacokinetics and pharmacodynamics of drugs. The advantages and limitations of each approach usually determine its application, and therefore a small-rodent imaging laboratory in a pharmaceutical environment should ideally provide access to several techniques. In this paper we aim to illustrate how these techniques may be used to obtain meaningful information for the phenotyping of transgenic mice and for the analysis of compounds in murine models of disease. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:154 / 185
页数:32
相关论文
共 313 条
[41]   Immunopathogenesis of collagen arthritis [J].
Brand, DD ;
Kang, AH ;
Rosloniec, EF .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 25 (01) :3-18
[42]   Tau alteration and neuronal degeneration in tauopathies: mechanisms and models [J].
Brandt, R ;
Hundelt, M ;
Shahani, N .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3) :331-354
[43]  
Bresnihan B, 1999, J RHEUMATOL, V26, P717
[44]   Validation and calibration of DEXA body composition in mice [J].
Brommage, R .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E454-E459
[45]   Optimal number of pinholes in multi-pinhole SPECT for mouse brain imaging - a simulation study [J].
Cao, ZX ;
Bal, G ;
Accorsi, R ;
Acton, PD .
PHYSICS IN MEDICINE AND BIOLOGY, 2005, 50 (19) :4609-4624
[46]   Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis [J].
Castellani, RJ ;
Smith, MA ;
Perry, G ;
Friedland, RP .
NEUROBIOLOGY OF AGING, 2004, 25 (05) :599-602
[47]  
Cavanaugh Dawn, 2004, Mol Imaging, V3, P55, DOI 10.1162/153535004773861723
[48]   Contrast enhancement in atherosclerosis development in a mouse model:: in vivo results at 2Tesla [J].
Chaabane, L ;
Pellet, N ;
Bourdillon, MC ;
Mansard, CD ;
Sulaiman, A ;
Hadour, G ;
Thivolet-Béjui, F ;
Roy, P ;
Briguet, A ;
Douek, P ;
Soulas, EC .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2004, 17 (3-6) :188-195
[49]   High-resolution magnetic resonance imaging at 2 Tesla: Potential for atherosclerotic lesions exploration in the apolipoprotein E knockout mouse [J].
Chaabane, L ;
Soulas, EC ;
Contard, F ;
Salah, A ;
Guerrier, D ;
Briguet, A ;
Douek, P .
INVESTIGATIVE RADIOLOGY, 2003, 38 (08) :532-538
[50]   A longitudinal magnetic resonance imaging (MRI) study of differences in abdominal fat distribution between normal mice, and lean overexpressors of mitochondrial uncoupling protein-3 (UCP-3) [J].
Changani, KK ;
Nicholson, A ;
White, A ;
Latcham, JK ;
Reid, DG ;
Clapham, JC .
DIABETES OBESITY & METABOLISM, 2003, 5 (02) :99-105